Tongling Jieya Biologic Technology Co. Ltd.
Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sales of wet wipe products in China. It offers baby, adult functional, antibacterial and disinfection, household clearing, medical care, pet cleaning wipes, wet toilet papers. The company also provides beauty care products, such as emollient water, Lotion, Cream, Essence, Membranes, clean, Body S… Read more
Tongling Jieya Biologic Technology Co. Ltd. (301108) - Total Liabilities
Latest total liabilities as of June 2025: CN¥330.27 Million CNY
Based on the latest financial reports, Tongling Jieya Biologic Technology Co. Ltd. (301108) has total liabilities worth CN¥330.27 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tongling Jieya Biologic Technology Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Tongling Jieya Biologic Technology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tongling Jieya Biologic Technology Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Tongling Jieya Biologic Technology Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
JETEMA Co. Ltd
KQ:216080
|
Korea | ₩156.25 Billion |
|
Zippy Technology Corp
TW:2420
|
Taiwan | NT$1.69 Billion |
|
Fifth Era Acquisition Corp I Class A Ordinary Shares
NASDAQ:FERA
|
USA | $13.67 Million |
|
Brazil Potash Corp.
NYSE:GRO
|
USA | $6.39 Million |
|
Zhejiang Guanghua Technology Co. Ltd. A
SHE:001333
|
China | CN¥1.09 Billion |
|
New Fortress Energy LLC
NASDAQ:NFE
|
USA | $10.78 Billion |
|
Shandong Swan Cotton
SHG:603029
|
China | CN¥1.40 Billion |
|
Jiangsu Topfly New Materials
SHE:001373
|
China | CN¥124.81 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Tongling Jieya Biologic Technology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tongling Jieya Biologic Technology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tongling Jieya Biologic Technology Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Tongling Jieya Biologic Technology Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥253.60 Million | -12.50% |
| 2023-12-31 | CN¥289.82 Million | +0.73% |
| 2022-12-31 | CN¥287.73 Million | -19.87% |
| 2021-12-31 | CN¥359.10 Million | -17.11% |
| 2020-12-31 | CN¥433.21 Million | +232.75% |
| 2019-12-31 | CN¥130.19 Million | -- |